EYPT · EyePoint, Inc.
$11.92
-0.04 (-0.33%)
At close · Jul 29
Market Cap
$999.39M
Shares
83.84M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$31.37M
-27.5%
FY2025
Net Income
-$231.96M
-77.2%
FY2025
Operating Margin
-775.98%
-438.9pp
FY2025
Diluted EPS
-$3.17
-36.6%
FY2025
Operating Cash Flow
-$240.11M
-90.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $7.61M | $31.37M | $43.27M | $46.02M | $41.4M | $36.94M | $34.44M | $20.37M | $4.57M | $7.54M | $1.62M | $26.57M | $3.47M | $2.14M | $3.53M | |
| $234.61M | $221.04M | $132.93M | $64.66M | $49.64M | $28.5M | $17.42M | $15.37M | $18.5M | $14.88M | $14.38M | $12.09M | $9.57M | $7.01M | $7.04M | |
| $58K | $90K | $131K | $11.69M | $25.51M | $27.5M | $25.29M | $29.77M | $9.66M | — | — | — | — | — | — | |
| $52.98M | $51.61M | $52.36M | $40.1M | $34.82M | $25.58M | $20.73M | $17.94M | $15.43M | $11.24M | $9.01M | $8.06M | $7.47M | $7.17M | $6.87M | |
| — | — | — | $0 | $2.05M | $2.46M | $2.46M | $2.46M | $981K | $724K | $756K | $770K | $778K | $769K | $2.04M | |
| $2.45M | $2.31M | $1.54M | $464K | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | $590K | — | $472K | $472K | — | — | — | — | — | |
| $289.44M | $274.81M | $189.13M | $121.09M | $141.04M | $92.22M | $71.73M | $68.23M | $43.59M | $26.12M | $23.39M | $20.14M | $16.96M | $14.17M | $28.74M | |
| -$281.82M | -$243.43M | -$145.85M | -$75.07M | -$99.64M | -$55.28M | -$37.29M | -$47.86M | -$39.02M | -$18.58M | -$21.77M | $6.42M | -$13.49M | -$12.03M | -$25.21M | |
| — | -775.98% | -337.06% | -163.13% | -240.65% | -149.64% | -108.28% | -235.02% | -853.62% | -246.4% | -1344.07% | 24.17% | -388.42% | -561.41% | -715% | |
| -$279.38M | -$241.13M | -$144.31M | -$74.6M | — | — | — | — | — | — | — | — | — | — | — | |
| — | $33K | $14K | $1.25M | $3.19M | $5.5M | $7.26M | $6.18M | $2.36M | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $19K | $6000 | $16K | $38K | |
| $10.45M | $11.75M | $15.07M | $4.36M | -$2.62M | -$3.14M | -$8.1M | -$8.93M | $420K | $91K | $72K | $22K | $5000 | $14K | $207K | |
| — | -$231.68M | -$130.78M | -$70.71M | -$102.25M | -$58.42M | -$45.39M | -$56.79M | -$53.17M | -$18.49M | -$21.7M | $6.44M | -$13.49M | -$12.02M | -$25M | |
| $229K | $279K | $90K | $83K | $0 | $0 | $0 | $0 | $0 | $0 | -$155K | $96K | -$130K | -$117K | -$169K | |
| -$271.6M | -$231.96M | -$130.87M | -$70.8M | -$102.25M | -$58.42M | -$45.39M | -$56.79M | -$86.13M | -$18.49M | -$21.55M | $6.35M | -$13.36M | -$11.9M | -$24.84M | |
| — | -739.42% | -302.43% | -153.84% | -246.97% | -158.14% | -131.82% | -278.88% | -1884.16% | -245.19% | -1330.06% | 23.89% | -384.54% | -555.3% | -704.34% | |
| -$271.72M | -$232.03M | -$130.71M | -$70.72M | -$102.31M | -$58.42M | -$45.39M | -$56.79M | -$53.17M | -$18.5M | -$21.64M | $6.25M | -$13.23M | -$11.92M | -$25.32M | |
| USD/shares | — | -$3.17 | -$2.32 | -$1.82 | -$2.74 | -$2.03 | — | — | — | -$5.20 | -$6.80 | $2.20 | — | — | -$11.90 |
| USD/shares | — | -$3.17 | -$2.32 | -$1.82 | -$2.74 | -$2.03 | — | — | — | -$5.20 | -$6.80 | $2.10 | — | — | -$11.90 |
| shares | — | 73.25K | 56.3K | 38.9K | 37.32M | 28.76M | 12.84M | 10.43M | 6.79M | 3.53M | 3.16M | 2.94M | 2.74M | 2.3M | 2.08M |
| shares | — | 73.25K | 56.3K | 38.9K | 37.32M | 28.76M | 12.84M | 10.43M | 6.79M | 3.53M | 3.16M | 3.06M | 2.74M | 2.3M | 2.08M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 7.78×
EV/EBIT
—
Peer median 17.62×
P/E (TTM)
—
Peer median 11.95×
Peer medians compare against the 294 similar-size Biotechnology companies (of 522 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| United States | $29,979,000 | $42,049,000 | $45,270,000 | $40,481,000 | $35,988,000 | $22,624,000 | $19,144,000 |
| China | $1,292,000 | $1,124,000 | $648,000 | $823,000 | $851,000 | $11,713,000 | $1,121,000 |
| United Kingdom | $100,000 | $100,000 | $100,000 | $100,000 | $100,000 | $100,000 | $100,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| License and Collaboration Agreement | $16,734,000 | $38,496,000 | $30,797,000 | $362,000 | $756,000 | $11,942,000 | $1,361,000 |
| Royalty | $13,041,000 | $1,613,000 | $989,000 | $1,137,000 | $871,000 | $1,664,000 | $2,180,000 |
| YUTIQ Product | $1,600,000 | $3,100,000 | $14,200,000 | $28,329,000 | $16,959,000 | $13,878,000 | $12,046,000 |
| Product | $1,596,000 | $3,164,000 | $14,232,000 | $39,905,000 | $35,312,000 | $20,831,000 | $16,824,000 |
| Collaborative Research and Development | — | — | — | $0 | $60,000 | $255,000 | — |
| DEXYCU Product | — | — | $0 | $11,576,000 | $18,353,000 | $6,953,000 | $4,778,000 |
Key facts
CIK
1314102
CUSIP
30233G209
13F (30d)
24 filings
24 filers
Visit website
Investor relations